MindMap Gallery First-Line FDA-Approved Treatments for Psychiatric Disorders
This mind map provides a detailed overview of FDA-approved first-line treatments for various psychiatric disorders, categorized into anxiety disorders, mood disorders, psychotic disorders, and other psychiatric conditions. Each category lists specific disorders along with their corresponding FDA-approved medications and treatments. The map serves as a quick reference guide for healthcare professionals, offering insights into the recommended treatments for conditions such as Generalized Anxiety Disorder, Major Depressive Disorder, Bipolar Mania, and Schizophrenia, among others.
Edited at 2025-07-21 15:48:49This mind map provides a comprehensive classification of psychopathology, detailing various categories of mental disorders. It starts with the main topic "Classification of Psychopathology" and branches out into major categories such as Neurocognitive Disorders, Mood Disorders, Psychotic Disorders, Anxiety Disorders, and more. Each category is further subdivided into specific disorders, with some including additional characteristics or criteria. For example, Substance Use Disorder lists Dx Criteria including tolerance, withdrawal, and social occupational decline. This visual representation helps in understanding the complex structure and relationships within psychopathology classifications.
This mind map provides a comprehensive overview of depressive disorders, focusing on diagnosis and assessment. It covers medications associated with depression, drugs of abuse that can induce depression, and secondary depression medical etiologies. The map details specific medical conditions that can lead to depression, such as neoplasms, immune disorders, cardiac conditions, endocrine disorders, and neurologic disorders. Additionally, it outlines the diagnosis criteria for substance/medication-induced depressive disorder and depression due to another medical condition, highlighting core symptoms and contributing factors.
This mind map provides a detailed overview of FDA-approved first-line treatments for various psychiatric disorders, categorized into anxiety disorders, mood disorders, psychotic disorders, and other psychiatric conditions. Each category lists specific disorders along with their corresponding FDA-approved medications and treatments. The map serves as a quick reference guide for healthcare professionals, offering insights into the recommended treatments for conditions such as Generalized Anxiety Disorder, Major Depressive Disorder, Bipolar Mania, and Schizophrenia, among others.
This mind map provides a comprehensive classification of psychopathology, detailing various categories of mental disorders. It starts with the main topic "Classification of Psychopathology" and branches out into major categories such as Neurocognitive Disorders, Mood Disorders, Psychotic Disorders, Anxiety Disorders, and more. Each category is further subdivided into specific disorders, with some including additional characteristics or criteria. For example, Substance Use Disorder lists Dx Criteria including tolerance, withdrawal, and social occupational decline. This visual representation helps in understanding the complex structure and relationships within psychopathology classifications.
This mind map provides a comprehensive overview of depressive disorders, focusing on diagnosis and assessment. It covers medications associated with depression, drugs of abuse that can induce depression, and secondary depression medical etiologies. The map details specific medical conditions that can lead to depression, such as neoplasms, immune disorders, cardiac conditions, endocrine disorders, and neurologic disorders. Additionally, it outlines the diagnosis criteria for substance/medication-induced depressive disorder and depression due to another medical condition, highlighting core symptoms and contributing factors.
This mind map provides a detailed overview of FDA-approved first-line treatments for various psychiatric disorders, categorized into anxiety disorders, mood disorders, psychotic disorders, and other psychiatric conditions. Each category lists specific disorders along with their corresponding FDA-approved medications and treatments. The map serves as a quick reference guide for healthcare professionals, offering insights into the recommended treatments for conditions such as Generalized Anxiety Disorder, Major Depressive Disorder, Bipolar Mania, and Schizophrenia, among others.
First-Line FDA-Approved Treatments for Psychiatric Disorders
I Anxiety Disorders ☁️
Generalised Anxiety Disorder GAD
Class SSRIs and SNRIs
Specific FDAApproved Medications
SSRIs Paroxetine, Escitalopram
SNRIs Duloxetine, Venlafaxine
Note Bupropion not effective for panic Pregabalin offlabel for GAD
Panic Disorder
Class SSRIs/SNRIs
Specific FDAApproved Medications
SSRIs Paroxetine, Sertraline, Fluoxetine
SNRI Venlafaxine
Benzodiazepines Alprazolam, Clonazepam
Social Anxiety Disorder SAD
Class SSRIs
Specific FDAApproved Medications
SSRIs Paroxetine, Sertraline, Fluvoxamine CR
SNRI Venlafaxine
II Mood Disorders 🌈
Major Depressive Disorder MDD
Class SSRIs
Specific FDAApproved Medications
SSRIs Fluoxetine, Paroxetine, Sertraline, Citalopram, Escitalopram
SNRIs Venlafaxine, Desvenlafaxine, Duloxetine, Levomilnacipran
Recently Approved Agents Vortioxetine, Vilazodone
Pediatric MDD
Fluoxetine ages 8+, Escitalopram ages 12+
Adjunctive for TreatmentResistant Depression
Olanzapine/Fluoxetine Combination, Aripiprazole, Quetiapine, Brexpiprazole
Postpartum Depression
Brexanolone first FDAapproved medication
Note Fluvoxamine only for OCD, Trazodone not FDAapproved for insomnia
Bipolar Mania Acute
Mood Stabilizers
Lithium ages 7+ for Bipolar I
Divalproex ages 10+
Carbamazepine ExtendedRelease
SecondGeneration Antipsychotics SGAs
Olanzapine, Quetiapine, Aripiprazole, Risperidone, Ziprasidone, Asenapine, Cariprazine
Note Paliperidone not FDAapproved for acute mania
Bipolar Depression
Specific FDAApproved Medications
Olanzapine/Fluoxetine Combination OFC
Quetiapine monotherapy
Lurasidone monotherapy, adjunct to lithium or valproate
Cariprazine
Note Lamotrigine FDAapproved for maintenance, not acute depression
III Psychotic Disorders 🌌
Schizophrenia
FirstEpisode Psychosis FEP
Aripiprazole, Olanzapine, Risperidone
Haloperidol if others ineffective
General Treatment FDAApproved SGAs
Aripiprazole, Risperidone, Olanzapine, Quetiapine, Lurasidone, Paliperidone, Brexpiprazole
Recurrent Suicidal Behavior
Specific FDAApproved Medication
Clozapine most effective, not firstline due to side effects
Refractory Schizophrenia
Specific FDAApproved Medication
Clozapine more effective than thioridazine
IV Other Psychiatric Disorders 🌼
AttentionDeficit/Hyperactivity Disorder ADHD
Class Psychostimulants
Specific FDAApproved Stimulants
Methylphenidate ages ≥6, Amphetamine salts ages ≥3
Specific FDAApproved NonStimulants
Atomoxetine ages ≥6, Clonidine ER, Guanfacine ER, Viloxazine ages 617
Autism Spectrum Disorder ASD Irritability
Specific FDAApproved Medications
Risperidone ages 516, Aripiprazole ages 617
Binge Eating Disorder BED
Specific FDAApproved Medication
Lisdexamfetamine first drug approved for BED
Bulimia Nervosa BN
Specific FDAApproved Medication
Fluoxetine only FDAapproved drug dosage 60 mg/day
Delirium
No FDAApproved Pharmacological Intervention
Note Antipsychotics used offlabel, carry FDA warning
Dementia Secondary to Parkinson's Disease
Specific FDAApproved Medication
Rivastigmine
Fibromyalgia
Specific FDAApproved Medications
Pregabalin, Duloxetine, Milnacipran
Female Sexual Dysfunction HSDD
Specific FDAApproved Medication
Flibanserin first and only for premenopausal women
Insomnia
Specific FDAApproved Medications
Suvorexant, Flurazepam, Zolpidem, Doxepin
Note Trazodone not FDAapproved for insomnia
ObsessiveCompulsive Disorder OCD
Class SSRIs firstline
Specific FDAApproved Medications
SSRIs Fluoxetine ages 718, Fluvoxamine ages 817, Sertraline ages 617, Paroxetine
TCA Clomipramine ages 10+
Opioid Use Disorder OUD
Specific FDAApproved Medications
Methadone, Oral Naltrexone, Buprenorphine, Injectable LongActing Naltrexone
Parkinson's Disease Psychosis
FirstLine Medication
Quetiapine
Specific FDAApproved Medication
Pimavanserin firstinclass 5HT2A receptor inverse agonist
PostTraumatic Stress Disorder PTSD
Class SSRIs only FDAapproved class
Specific FDAApproved Medications
Sertraline, Paroxetine
Note Fluoxetine, Venlafaxine comparable but not FDAapproved for PTSD
Restless Legs Syndrome RLS
Specific FDAApproved Medication
Gabapentin as gabapentin enacarbil
Tourette's Syndrome
Specific FDAApproved Medications
Aripiprazole ages 618, Pimozide ages 8+, Haloperidol
Tardive Dyskinesia TD
Specific FDAApproved Medications
Valbenazine, Deutetrabenazine
Note Tetrabenazine used offlabel for TD